Search

Your search keyword '"Graves Ophthalmopathy epidemiology"' showing total 184 results

Search Constraints

Start Over You searched for: Descriptor "Graves Ophthalmopathy epidemiology" Remove constraint Descriptor: "Graves Ophthalmopathy epidemiology"
184 results on '"Graves Ophthalmopathy epidemiology"'

Search Results

1. Age and gender influence on clinical manifestations of thyroid-associated ophthalmopathy: a case series of 2479 Chinese patients.

2. Graves' orbitopathy development in thyroid cancer patients: a 16-year nationwide cohort study in South Korea.

3. Intraocular and extraocular manifestations of thyroid dysfunction in Danish patients: A Nationwide Study.

4. Euthyroid graves' ophthalmopathy in a Chinese population: A cross-sectional follow-up study.

5. Temporal trends in the clinical presentation of Graves' orbitopathy: a single-center retrospective study.

6. Thyroid Eye Disease: Pilot Study Comparison Between Patients in United States-Based and India-Based Practices.

7. Intraocular and extraocular manifestations of thyroid dysfunction in Danish patients-A nationwide study.

8. Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease.

9. IgG4 serum levels in Graves' orbitopathy.

10. [Graves' orbitopathy as the cause of diplopia in old age-Differences between young and old].

11. Prevalence, Clinical and Imaging Characteristics of Superior Ophthalmic Vein Periphlebitis in Thyroid Eye Disease.

12. Predictive model for the progression of inactive thyroid eye disease: a retrospective study.

13. The Role of FOXP3 Polymorphisms in Graves' Disease with or without Ophthalmopathy in a Turkish Population.

16. Radioactive iodine treatment for Graves' hyperthyroidism: incidence of Graves orbitopathy.

17. Thyroid eye disease in Eastern Province of Saudi Arabia: clinical profile and correlation with vitamin D deficiency.

18. Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III).

19. Prevalence, Risk Factors, and Clinical and Biochemical Characteristics of Alemtuzumab-Induced Graves Disease.

20. Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination.

21. Alemtuzumab induces severe orbitopathy in relapsing-remitting multiple sclerosis.

23. Assessment of risk of obstructive sleep apnea with thyroid eye disease and its activity.

24. Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors.

25. Incidence and risk factors for Graves' orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves' disease: investigation of 1,553 cases with newly diagnosed Graves' disease and proposal of a predictive score.

26. Expanding Understanding of Thyroid Eye Disease Manifestations to Include Hispanic and Black Patients.

27. How patients experience thyroid eye disease.

28. Sex-specific risk factors associated with graves' orbitopathy in Korean patients with newly diagnosed graves' disease.

29. Thyroid Eye Disease and its Vision-Threatening Manifestations in the Academy IRIS Registry: 2014-2018.

30. Associations Between Thyroid Eye Disease and Glaucoma Among Those Enrolled in the National Institutes of Health All of Us Research Program.

31. Influence of biological sex, age and smoking on Graves' orbitopathy - a ten-year tertiary referral center analysis.

32. Risk factors for development of superior limbic keratoconjunctivitis in thyroid eye disease in Japanese.

33. Clinical characteristics and the treatment modalities of Graves' orbitopathy in a tertiary referral center in Turkey: changes over two decades.

34. Incidence of A pattern strabismus after inferior rectus recession in patients with Graves' orbitopathy: A retrospective multicentre study.

35. Novel Insight into Non-Genetic Risk Factors of Graves' Orbitopathy.

36. Predictive Model for Graves' Ophthalmopathy in Patients with New-Onset Graves' Disease.

37. Current concepts regarding Graves' orbitopathy.

38. Glucocorticoid therapy reduces ocular hypertension in active moderate-severe thyroid-associated orbitopathy.

39. Inflammatory and Noninflammatory Thyroid Eye Disease: Comparison of Disease Signs, Symptoms, and Quality of Life in Patients in the United States.

40. Clinical profile of 80-year-old and older thyroid eye disease patients.

41. Update on thyroid eye disease: Regional variations in prevalence, diagnosis, and management.

42. Nationwide Incidence of Thyroid Eye Disease and Cumulative Incidence of Strabismus and Surgical Interventions in Denmark.

43. 2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease.

45. [LIFESTYLE ADJUSTMENT AS THERAPEUTIC TOOL IN THYROID EYE DISEASE].

46. [Graves' orbitopathy: diagnosis, epidemiology and treatments].

47. The risk factors for Graves' ophthalmopathy.

48. Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO): results of a large cohort study.

49. Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres.

50. Trends in Graves' orbitopathy research in the past two decades: a bibliometric analysis.

Catalog

Books, media, physical & digital resources